Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a M cell‐targeted microparticulate platform, BSK02™, for oral immunization against the ovarian cancer antigen, sperm protein 17

Published:2018-03-04 Issue:1 Volume:107 Page:29-36
ISSN:1552-4973
Container-title:Journal of Biomedical Materials Research Part B: Applied Biomaterials
language:en
Short-container-title:J. Biomed. Mater. Res.

Author:

Mattila Juha‐Pekka¹,Mirandola Leonardo¹,Chiriva‐Internati Maurizio¹²

Affiliation:

1. Kiromic BioPharma, 7707 Fannin St., Suite 140Houston Texas77054

2. The University of Texas MD Anderson Cancer Center, Department of Lymphoma and Myeloma, and Department of Gastroenterology Hepatology and Nutrition, 1515 Holcombe BlvdHouston Texas77030

Funder

National Institutes of Health

Publisher

Wiley

Subject

Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbm.b.34092

Reference43 articles.

1. Recent progress in the diagnosis and treatment of ovarian cancer

2. Immunotherapy for ovarian cancer

3. Cancer Testis Antigens: Novel Biomarkers and Targetable Proteins for Ovarian Cancer

4. Novel strategies for immunotherapy in multiple myeloma: Previous experience and future directions;Danylesko I;Clin Dev Immunol,2012

5. MAGE‐A antigens and cancer immunotherapy;Zajac P;Front Med (Lausanne),2017

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oral Cell-Targeted Delivery Systems Constructed of Edible Materials: Advantages and Challenges;Molecules;2022-11-17

2. Mucosal vaccine delivery: A focus on the breakthrough of specific barriers;Acta Pharmaceutica Sinica B;2022-09

3. Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines;Biomaterials;2022-01

4. Sperm protein 17 targeting for epithelial ovarian cancer treatment in the era of modern immunoengineering;Molecular Therapy - Oncolytics;2021-12

5. Advanced oral vaccine delivery strategies for improving the immunity;Advanced Drug Delivery Reviews;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3